Role of extracellular signal-regulated kinase for endothelial progenitor cell dysfunction in coronary artery disease

Area of Science:

• Cardiovascular Biology
• Cellular Signaling
• Regenerative Medicine

Background:

• Endothelial progenitor cells (EPCs) play a crucial role in vascular repair.
• Reduced number and function of EPCs are observed in patients with coronary artery disease (CAD).
• Intracellular signaling pathways governing EPC dysfunction in CAD are not fully understood.

Purpose of the Study:

• To investigate the regulation of extracellular signal-regulated kinase (ERK)-1/2 by stromal cell-derived factor-1 (SDF-1) in EPCs.
• To determine the role of ERK-1/2 signaling in EPC adhesion under flow conditions.
• To explore potential therapeutic targets for improving EPC function in CAD.

Main Methods:

• Western blot analysis to assess ERK-2 phosphorylation in response to SDF-1.
• Isolation and culture of EPCs from healthy controls and CAD patients.
• Functional adhesion assays of EPCs under flow conditions.
• Genetic manipulation (MEK-2 cDNA construct) to augment ERK-2 signaling.

Main Results:

• SDF-1 induced a rapid and robust ERK-2 phosphorylation in EPCs from healthy subjects.
• EPCs from CAD patients exhibited delayed and attenuated SDF-1-triggered ERK-2 phosphorylation.
• CAD-EPCs showed significantly reduced SDF-1-induced adhesion under flow.
• Activating ERK-2 signaling via MEK-2 restored adhesion capacity in CAD-EPCs.

Conclusions:

• Defects in SDF-1-mediated EPC adhesion contribute to EPC functional impairment in CAD.
• ERK-2 signaling is a critical mediator of EPC adhesion in response to SDF-1.
• Targeting ERK-2 signaling presents a potential therapeutic strategy to enhance EPC adhesion and function in CAD patients.